Case Study: International Phase 1 Non-small Cell Lung Cancer (NSCLC) Trial
|
Precision for Medicine delivers early phase clinical trials with integrated services, expertise in Oncology & Rare Disease, and advanced methodologies to significantly shorten your development timelines. Engage with us to propel your groundbreaking therapies from concept through early-stage clinical success with unparalleled speed and precision.
At the core of Precision for Medicine's early phase clinical trials is a pioneering spirit and a steadfast commitment to Oncology and Rare Disease research. This dedication is the driving force behind our deep domain expertise, enabling us to tackle ambitious trial designs and complex challenges head-on. In the realm of oncology and rare diseases, where every study can be a voyage into uncharted territory, Precision for Medicine stands at the forefront of innovation and steadfast resolve. Our team excels in managing the intricate maze of data points that these trials generate, ensuring that each piece of information is leveraged to its fullest potential to illuminate the path toward groundbreaking therapies.
Augmented by cutting-edge technologies and supported by teams of industry veterans, we create a strategic advantage for our client sponsors that is unparalleled. It is this fusion of technological innovation, operational excellence, and a deep understanding of patient care that enables us to transform ambitious visions into tangible successes, paving the way for the next generation of clinical breakthroughs.
Transform ambitious trial designs into actionable plans with our domain expertise in Oncology and Rare Diseases. We craft flexible operational strategies, translating intricate designs into optimized protocols for successful studies. By translating intricate designs into optimized protocols, we pave the way for your study's success — delivered with the precision you need for this pivotal stage of clinical discovery.
Embrace the advantages of seamless Phase 1/2 study designs. This approach can accelerate and compress the timelines of your clinical development journey. Discover Precision’s best practices for seamless Phase 1 - 2 study planning and execution. Learn more in our latest eBook.
Unlock the full potential of your early phase trials with Precision’s specialty lab services. Our expert assay development and validation not only enhance the accuracy and reliability of your data but also streamline your path to milestone achievements. Discover how our tailored lab solutions can revolutionize your therapy's journey from lab bench to clinical success.
Read the latest case studies and insights from the front lines of clinical development.
Discover how Precision for Medicine's proprietary technologies like ApoStream® for CTC liquid biopsy and Epiontis ID® for immune cell profiling are revolutionizing early-phase trials. These innovations offer rare cell enrichment, immune monitoring, and precise cell count capabilities, enhancing trial efficiency and data quality. Dive into how our technological advancements can elevate your clinical development program.
Discover Precision's end-to-end manufacturing advisory, from preclinical to commercial scale. Specializing in advanced therapy medicinal products, we provide strategic planning, process optimization, facility design, and regulatory guidance. Our Manufacturing Solutions team at Precision for Medicine, formerly known as Project Farma, ensures your therapy's scalable production and accelerated market entry. Learn how our comprehensive services can navigate your product through complex manufacturing challenges to successful launch.
Enhance your access to capital with Stern IR, a Precision company, renowned for expert investor relations for companies at all stages of development. With 25 years’ experience connecting novel science and medicine to the financial resources that enable novel therapeutic, we heighten your company’s visibility among investors and analysts and clearly communicate your medical innovations to this audience. Whether you're a preclinical startup or a late stage clinical trailblazer, our tailored IR approach is designed to secure the resources necessary for your clinical journey's success.
Craft an impactful value proposition early in your therapy's journey with Precision's HEOR and market access experts. We illuminate the path to market by aligning HEOR and access insights and strategy with your clinical development and investment plans. By highlighting unmet need, competitive landscape analyses, and stakeholder perspectives, we position your innovation for success. Our tailored solutions, including early economic modeling, ensure your therapy not only meets clinical goals but also showcases its real-world impact, enhancing appeal to investors and payers alike.
Discover our collection of resources designed to optimize and accelerate your early phase development, including our latest eBook on Seamless Phase 1-2 Study Best Practices.
Download & proceed with PrecisionAn integrated infrastructure that reduces the inefficiencies inherent in complex development
A recognized leader in oncology and rare diseases with rich experience in complex trials
Experts in translational and biomarker sciences with worldwide specialty labs and central lab services that are enabling breakthroughs.
Proven pioneer in planning, building and maintaining complex manufacturing facilities for biotech and large pharma.
With Precision, your pioneering treatments in Oncology, Rare Diseases, and beyond are propelled from concept to reality, supported by teams with deep domain expertise and innovative approaches
Stay informed with the latest insights from our experts, who share knowledge, trends, and success stories from the forefront of clinical research.